NeutropeniaFeverFebrile NeutropeniaChemotherapy-Induced Febrile NeutropeniaAntineoplastic Combined Chemotherapy ProtocolsEnterocolitis, NeutropenicTaxoidsGranulocyte Colony-Stimulating FactorDrug Administration ScheduleAgranulocytosisTreatment OutcomeChemotherapy, AdjuvantAntineoplastic AgentsCisplatinPaclitaxelNeoplasmsCyclophosphamideDoxorubicinMycosesInfusions, IntravenousDeoxycytidineFever of Unknown OriginVinblastineSurvival AnalysisHematologic NeoplasmsCombined Modality TherapyDisease-Free SurvivalAntineoplastic Agents, PhytogenicCarboplatinCamptothecinLung NeoplasmsSurvival RateOpportunistic InfectionsEtoposideBreast NeoplasmsMaximum Tolerated DoseBacterial InfectionsAntifungal AgentsAnti-Bacterial AgentsNeoplasm StagingIfosfamideThrombocytopeniaHematologic DiseasesImmunocompromised HostDose-Response Relationship, DrugOrganoplatinum CompoundsBacteremiaProspective StudiesAntibiotic ProphylaxisLeukopeniaFluorouracilAmphotericin BNeoadjuvant TherapyNeoplasm MetastasisCarcinoma, Non-Small-Cell LungEpirubicinNauseaPenicillanic AcidAntimetabolites, AntineoplasticAspergillosisPrognosisAnthracyclinesSalvage TherapyPiperacillinNeoplasm Recurrence, LocalLymphoma, Non-HodgkinAmikacinTime FactorsLeukocyte CountAdministration, OralMethotrexateGram-Negative Bacterial InfectionsFollow-Up StudiesVomitingDrug Resistance, NeoplasmMucositisRecurrenceAdenocarcinomaRetrospective StudiesLeucovorinInfectionLung Diseases, FungalDisease ProgressionCandidiasisDrug Therapy, CombinationCeftazidimeFeasibility StudiesRecombinant ProteinsEchinocandinsAntineoplastic Agents, AlkylatingOxonic AcidGram-Positive Bacterial InfectionsTegafurHematologyOvarian NeoplasmsMitoxantroneDrug-Related Side Effects and Adverse ReactionsAntibiotics, AntineoplasticEpisode of CareNeutrophils